GT Biopharma, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
GTBP on Nasdaq
Industry
Pharmaceutical Preparations
Location
8000 Marina Blvd, Suite 100, Brisbane, California

There are no Buy or Sell transactions made by insiders since 7/18/2023

GT Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Martin Breen Executive Chairman/Interim CEO, Director $246 K Aug 11, 2023
Manu Ohri CFO & Secretary $100 K Aug 11, 2023
Gregory Berk Pres. of R&D, CMO $79.8 K Jul 15, 2022
Gavin Choy Acting Chief Financial Officer Dec 31, 2021
Alan Urban Chief Financial Officer Jun 3, 2024
Charles J. Casamento Director Jun 16, 2023
Bruce Wendel Director Jan 27, 2023
Rajesh Shrotriya Director Jan 27, 2023

Recent Insider Transactions by Companies or Individuals for GT Biopharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership